Meanwhile, in breast cancer cells treated with Olaparib, withdrawing PER3 returned PER3 oscillation to baseline (Figure 7D,E and Figure S4E, Table S3, Supporting Information). The gene discussed is PER3; the disease is breast carcinoma.